Advertisement
Home Tags Cancer: Colon

Tag: Cancer: Colon

Fecal immunochemical tests can consistently detect colorectal cancer when used on an annual basis

Consistent CRC Detection Seen for Fecal Immunochemical Tests

0
Effectiveness of the test varies between 73 and 78 percent in years two through four
Nearly one in seven colorectal cancer patients are under 50

About 1 in 7 Colorectal Cancer Patients Younger Than 50

0
And younger patients more likely to have advanced-stage cancer

ASCO Gastrointestinal Cancers Symposium, Jan. 21-23

0
The ASCO 2016 Gastrointestinal Cancers Symposium The American Society of Clinical Oncology's 12th annual Gastrointestinal Cancers Symposium was held from Jan. 21 to...
Colon tumors that don't produce the protein CDX2 are more likely to recur following surgical removal in patients with stage II colon cancer

CDX2-Negative Colon Cancer May Need More Tx Post Surgery

0
Patients with CDX2-negative tumors more likely to benefit from chemo in addition to surgery
For patients with stage III colon cancer treated with leucovorin

KRAS, BRAF V600E Mutations Impact Survival in Colon Cancer

0
Mutations linked to shorter survival in patients with microsatellite-stable tumors
Dietary glutamic acid intake is associated with reduced risk of developing colorectal cancer

Dietary Glutamic Acid Linked to Lower Risk of Colorectal Cancer

0
Significant reduction in risk for participants with body mass index of ≤25 kg/m²
Vistogard (uridine triacetate) has been approved by the U.S. Food and Drug Administration to treat an overdose of the chemotherapy drugs fluorouracil and capecitabine

FDA Approves Vistogard to Treat Chemotherapy Overdose

0
For overdose of the chemo drugs fluorouracil and capecitabine
A citywide colon cancer control coalition can increase colorectal cancer screening and address health disparities

Citywide Colon Cancer Control Coalition Ups Screening in NYC

0
Efforts of coalition increased screening colonoscopy from 42 percent in 2003 to almost 70 percent in 2014
Colorectal neoplasm is associated with smoking in a dose-response manner

Dose-Response Pattern for Smoking, Colorectal Neoplasm

0
Increase in non-advanced, advanced CRN with increasing smoking; no link for alcohol intake
For patients enrolled in metastatic colorectal cancer trials

Low BMI Linked to Increased Risk of Progression, Death in mCRC

0
Risk of progression and/or death highest for low BMI, decreases as BMI increases, then plateaus